Your browser doesn't support javascript.
loading
Antibody Persistence 1-5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12-23 Months of Age.
Tapia, Milagritos D; Findlow, Helen; Idoko, Olubukola T; Preziosi, Marie-Pierre; Kulkarni, Prasad S; Enwere, Godwin C; Elie, Cheryl; Parulekar, Varsha; Sow, Samba O; Haidara, Fadima Cheick; Diallo, Fatoumata; Doumbia, Moussa; Akinsola, Adebayo K; Adegbola, Richard A; Kampmann, Beate; Chaumont, Julie; Martellet, Lionel; Marchetti, Elisa; Viviani, Simonetta; Tang, Yuxiao; Plikaytis, Brian D; LaForce, F Marc; Carlone, George; Borrow, Ray.
Afiliação
  • Tapia MD; Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.
  • Findlow H; Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom.
  • Idoko OT; Vaccines and Immunity Theme, Medical Research Council Unit, Basse, The Gambia.
  • Preziosi MP; Meningitis Vaccine Project, PATH, Ferney-Voltaire, France Meningitis Vaccine Project, Department of Immunization, Vaccines and Biologicals, World Health Organization, Geneva, Switzerland.
  • Kulkarni PS; Serum Institute of India, Ltd, Pune.
  • Enwere GC; Meningitis Vaccine Project, PATH, Ferney-Voltaire, France.
  • Elie C; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Parulekar V; DiagnoSearch Life Sciences, Mumbai, India.
  • Sow SO; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Haidara FC; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Diallo F; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Doumbia M; Centre pour le Développement des Vaccins, Ministère de la Santé, Bamako, Mali.
  • Akinsola AK; Vaccines and Immunity Theme, Medical Research Council Unit, Basse, The Gambia.
  • Adegbola RA; GlaxoSmithKline Vaccines, Wavre, Belgium.
  • Kampmann B; Vaccines and Immunity Theme, Medical Research Council Unit, Basse, The Gambia.
  • Chaumont J; Meningitis Vaccine Project, PATH, Ferney-Voltaire, France.
  • Martellet L; Meningitis Vaccine Project, PATH, Ferney-Voltaire, France.
  • Marchetti E; Meningitis Vaccine Project, PATH, Ferney-Voltaire, France.
  • Viviani S; Meningitis Vaccine Project, PATH, Ferney-Voltaire, France.
  • Tang Y; Meningitis Vaccine Project, PATH, Seattle, WA.
  • Plikaytis BD; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • LaForce FM; Serum Institute of India, Ltd, Pune.
  • Carlone G; Centers for Disease Control and Prevention, Atlanta, Georgia.
  • Borrow R; Vaccine Evaluation Unit, Public Health England, Manchester Royal Infirmary, United Kingdom.
Clin Infect Dis ; 61 Suppl 5: S514-20, 2015 Nov 15.
Article em En | MEDLINE | ID: mdl-26553683

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atividade Bactericida do Sangue / Vacinas Meningocócicas / Anticorpos Antibacterianos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Atividade Bactericida do Sangue / Vacinas Meningocócicas / Anticorpos Antibacterianos Idioma: En Ano de publicação: 2015 Tipo de documento: Article